Casandra
Casandra Test Code GE39337Version 1 (DRAFT)
Performing Lab
Lab GeneDxLab Test ID TH01
Nephrolithiasis and Nephrocalcinosis Panel
Clinical Use
Order TestUse
Genetic evaluation of individuals with a history or clinical suspicion of nephrolithiasis or nephrocalcinosis to identify pathogenic variants in genes known to contribute to stone formation or renal calcification.
Special Instructions
Not provided.
Limitations
Technical analytical limitations not explicitly stated on provided content. Refer to GeneDx website for up‑to‑date limitations and gene coverage.
Test Details
New York Approved
Methodology
NGS (Targeted)
Biomarkers
NGS sequencing with CNV analysis • Targeted
Result Turnaround Time
14-28 days
Related Documents
For more information, please review the documents below
Specimen Requirements
Specimen
Whole Blood
Volume
Not provided
Minimum Volume
Not provided
Similar Tests
Other tests from different labs that may be relevant
Nephrolithiasis and Nephrocalcinosis Panel
Prevention Genetics
Invitae Nephrolithiasis Panel
Invitae Corporation
Nephrocalcinosis, Nephrolithiasis, and Renal Electrolyte Imbalance Gene Panel, Varies
Mayo Clinic Lab
Cystinuria Panel
Prevention Genetics
Invitae Nephronophthisis Panel
Invitae Corporation
Comprehensive Nephrology Gene Panel, Varies
Mayo Clinic Lab
PGmax™ - Comprehensive Inherited Kidney Diseases Panel
Prevention Genetics
Distal Renal Tubular Acidosis Panel
Prevention Genetics
Hereditary Cystic Kidney Diseases Panel
Prevention Genetics
Invitae Renal Tubular Disorders Panel
Invitae Corporation